Unresectable Stage III or IV Malignant Melanoma
1 clinical trials · Condition
◉ Watch Unresectable Stage III or IV Malignant Melanoma
| Record | Firm | Date |
|---|---|---|
| Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) (NCT00261365) | Bristol-Myers Squibb | 2005-11-01 |
Track Unresectable Stage III or IV Malignant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.